David O. Taylor, MD

Article

In reply: The PARADIGM-HF trial

Author:: David O. Taylor, MD

Publish date: March 1, 2016

The findings of PARADIGM-HF have sparked much conversation and implementation of practice change in the treatment of heart failure.

Article

A new class of drugs for systolic heart failure: The PARADIGM-HF study

Author:: David O. Taylor, MD

Publish date: October 1, 2015

Valsartan-sacubitril is the first new drug in over a decade to decrease death rates in patients with systolic heart failure.

Article

Can patients with COPD or asthma take a beta-blocker?

Author:: David O. Taylor, MD

Publish date: August 1, 2010

Yes, if they really need one. We would choose a cardioselective agent.

Article

And an ARB makes nine: Polypharmacy in patients with heart failure

Author:: David O. Taylor, MD

Publish date: August 1, 2004

Based on strong evidence, a patient with advanced ischemic cardiomyopathy should be taking nine medications. But it is difficult not to worry about...